Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New developments in the urokinase-type plasminogen activator system.

Steven Rosenberg1

  • 1MCB Dept. Rm 229, University of California, Berkeley, California 94720-3206 USA. Srbchem@pacbell.net

Expert Opinion on Therapeutic Targets
|January 24, 2003
PubMed
Summary

The urokinase-type plasminogen activator (uPA) system, involved in cancer progression, has complex roles beyond simple enzyme inhibition. New insights reveal novel drug targets within the uPA system, including PAI-1 and uPAR interactions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Individual Profound Autism Criteria and Unmet Needs Among Autistic Adolescents and Their Caregivers.

JAMA pediatrics·2026
Same author

Vaccination rescues dysfunctional T cell therapy by amplifying rare stem-like antitumor CD8<sup>+</sup> T cells.

Research square·2026
Same author

Racial and ethnic disparities in the co-occurrence of intellectual disability and autism: Impact of incorporating measures of adaptive functioning.

Autism research : official journal of the International Society for Autism Research·2024
Same author

Risk factors and clinical correlates of sensory dysfunction in preschool children with and without autism spectrum disorder.

Autism research : official journal of the International Society for Autism Research·2023
Same author

Using adaptive behavior scores to convey level of functioning in children with autism spectrum disorder: Evidence from the Study to Explore Early Development.

Autism : the international journal of research and practice·2023
Same author

Differential Performance of Social Communication Questionnaire Items in African American/Black vs. White Children.

Journal of autism and developmental disorders·2023

Area of Science:

  • Biochemistry and Molecular Biology
  • Cancer Biology
  • Cellular Signaling

Background:

  • The urokinase-type plasminogen activator (uPA) system is crucial for extracellular matrix degradation and cell surface proteolysis.
  • Upregulation of uPA system components is observed in various human cancers, correlating with poorer prognosis.
  • Recent research highlights the complex roles of plasminogen activator inhibitor-1 (PAI-1) and the urokinase receptor (uPAR) within this system.

Purpose of the Study:

  • To explore the intricate functions of the uPA system, particularly PAI-1 and uPAR, in cancer.
  • To identify novel therapeutic targets for cancer drug discovery based on emerging complexities of the uPA system.

Main Methods:

  • Review and synthesis of recent research on the uPA system's components and their interactions.

Related Experiment Videos

  • Analysis of the roles of PAI-1 in pathological angiogenesis.
  • Investigation of uPAR's involvement in proteolysis, cellular adhesion, and intracellular signaling pathways.

    • Main Results:

    • PAI-1 significantly contributes to pathological angiogenesis.
    • uPAR acts as an adhesion receptor for vitronectin and modulates integrin signaling.
    • uPA binding to uPAR triggers intracellular signaling cascades involving integrins and G proteins.

    Conclusions:

    • The uPA system's complexity extends beyond enzyme inhibition, involving intricate interactions with PAI-1 and uPAR.
    • uPAR mediates crucial cellular processes including adhesion and signaling, making it a key player in cancer.
    • These complex interactions present novel drug discovery opportunities targeting the uPA system for cancer therapy.